Ursodeoxycholic acid efficacy studies

Ursodeoxycholic acid (UDCA) has been studied for its ability to improve liver conditions, particularly primary biliary cholangitis (PBC). Research shows that UDCA can slow disease progression, improve liver enzyme levels, and delay the need for liver transplants in many patients. It works by reducing inflammation and helping bile flow more normally. While it’s effective for some, response varies; not all patients experience the same benefits. Overall, clinical studies support UDCA as a standard treatment option to manage liver disease and improve quality of life for many individuals.